Advanced Therapies, LLC Email Format

Biotechnology ResearchPennsylvania, United States51-200 Employees

Advanced Therapies, LLC is a mid-sized biotechnology service provider operating as a cell therapy contract testing, development and manufacturing organization. It offers development, manufacturing, and testing capabilities to help advanced therapies progress from concept to release more quickly and with greater predictability, reducing the complexities and costs of coordinating multiple vendors. The company is based in Philadelphia, Pennsylvania. Its client base comprises developers of cell-based therapies seeking integrated support across development, manufacturing, and release testing.

In March 2025, Advanced Therapies U.S. and its discovery arm OXGENE were acquired by Altaris, a healthcare-focused investment firm. Altaris intends to merge Advanced Therapies with Minaris Regenerative Medicine to create Minaris Advanced Therapies, with full integration expected by the end of 2025; for now, the two entities will operate independently to ensure business continuity during separation milestones. This strategic move situates the company within a broader effort to expand capacity and capabilities in the cell and gene therapy manufacturing ecosystem.

Sign up for free to view info

Company overview Employee directory